A pilot study examining the role of zileuton in atopic dermatitis (Q41711836)

7 October 2017

title

A pilot study examining the role of zileuton in atopic dermatitis (English)

1 reference

7 October 2017

D P Woodmansee

1

1 reference

7 October 2017

R A Simon

series ordinal

2

1 reference

7 October 2017

publication date

1 December 1999

1 reference

Annals of Allergy, Asthma & Immunology

7 October 2017

published in

1 reference

7 October 2017

volume

83

1 reference

7 October 2017

issue

6 Pt 1

1 reference

7 October 2017

page(s)

548-552

1 reference

The natural history of childhood eczema: observations from the British 1958 birth cohort study

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

Leukotriene B4 in atopic dermatitis: increased skin levels and altered sensitivity of peripheral blood T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962868-2

7 January 2021

10.1016/S1081-1206(10)62868-2

Identifiers

DOI

1 reference

7 October 2017

1 reference